Alembic Pharmaceuticals informs about demise of senior management personnel
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed about the sad demise of Saibal Mukherjee, Resident Director (Delhi Office) of the Company on 26th April, 2026. Saibal Mukherjee joined the Company in 2014 and had been an integral part of the organisation. His sudden and unexpected demise will be an irreparable loss to the Company and all the directors and employees of the Company convey deep sympathy, sorrow and condolences to his family. The details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 is attached as Annexure-A.
The above information is a part of company’s filings submitted to BSE.
